Skip to main content
Erschienen in: Internal and Emergency Medicine 5/2022

09.07.2022 | IM - COMMENTARY

The unsolved mystery of MEFV variants variable expressivity in Familial Mediterranean Fever

verfasst von: Alessandro Stella, Piero Portincasa

Erschienen in: Internal and Emergency Medicine | Ausgabe 5/2022

Einloggen, um Zugang zu erhalten

Excerpt

Familial Mediterranean Fever (FMF) is the most common and best-known hereditary monogenic recurrent fever syndrome [1]. FMF is an autoinflammatory disorder caused by mutations in the MEFV gene which encodes for the pyrin (marenostrin) protein. Pyrin plays a crucial role in the cell response to several damage- and pathogen-associated molecular patterns (DAMPs and PAMPs, respectively). Via its interaction with the apoptosis-associated speck-like protein containing a CARD (ASC or PYCARD) and procaspase-1, pyrin promotes the release of pro-inflammatory cytokines, namely interleukin (IL)-1b and IL-18 [2]. Although traditionally considered an autosomal recessive disorder, FMF cases associated with a single MEFV mutation or with apparently dominant transmission are increasingly recognized [26]. In addition, FMF shows a strikingly unique prevalence with most patients’ clusters identified in countries bordering the Mediterranean basin, hence its name. Indeed, the FMF prevalence has been calculated as high as 1 in 400/500 in Anatolia and Armenia, 1 in 1000 in the rest of Turkey and in Israel and frequent in other Middle East countries, such as Lebanon, Syria, Jordan, and Iran [7]. In Italy, although no formal epidemiological studies have been performed, FMF has an estimated prevalence ranging from 1/2000 to 1/10000, therefore considered a rare disease (renderPdf.spring (salute.gov.it)). …
Literatur
2.
Zurück zum Zitat Fukushima Y, Obara K, Hirata H, Sugiyama K, Fukuda T, Takabe K (2013) Three Japanese patients (mother and two children) with familial Mediterranean fever associated with compound heterozygosity for L110P/E148Q/M694I and an autosomal true dominant inheritance pattern. Asian Pac J Allergy Immunol 31(4):325–329. https://doi.org/10.12932/AP0244.31.4.2013CrossRefPubMed Fukushima Y, Obara K, Hirata H, Sugiyama K, Fukuda T, Takabe K (2013) Three Japanese patients (mother and two children) with familial Mediterranean fever associated with compound heterozygosity for L110P/E148Q/M694I and an autosomal true dominant inheritance pattern. Asian Pac J Allergy Immunol 31(4):325–329. https://​doi.​org/​10.​12932/​AP0244.​31.​4.​2013CrossRefPubMed
3.
Zurück zum Zitat Stoffels M, Szperl A, Simon A, Netea MG, Plantinga TS, van Deuren M, Kamphuis S, Lachmann HJ, Cuppen E, Kloosterman WP, Frenkel J, van Diemen CC, Wijmenga C, van Gijn M, van der Meer JW (2014) MEFV mutations affecting pyrin amino acid 577 cause autosomal dominant autoinflammatory disease. Ann Rheum Dis 73(2):455–461. https://doi.org/10.1136/annrheumdis-2012-202580CrossRefPubMed Stoffels M, Szperl A, Simon A, Netea MG, Plantinga TS, van Deuren M, Kamphuis S, Lachmann HJ, Cuppen E, Kloosterman WP, Frenkel J, van Diemen CC, Wijmenga C, van Gijn M, van der Meer JW (2014) MEFV mutations affecting pyrin amino acid 577 cause autosomal dominant autoinflammatory disease. Ann Rheum Dis 73(2):455–461. https://​doi.​org/​10.​1136/​annrheumdis-2012-202580CrossRefPubMed
6.
Zurück zum Zitat Rowczenio DM, Youngstein T, Trojer H, Omoyinmi E, Baginska A, Brogan P, Papadopoulou C, Rezk T, Hawkins PN, Lachmann HJ (2020) British kindred with dominant FMF associated with high incidence of AA amyloidosis caused by novel MEFV variant, and a review of the literature. Rheumatology 59(3):554–558. https://doi.org/10.1093/rheumatology/kez334CrossRefPubMed Rowczenio DM, Youngstein T, Trojer H, Omoyinmi E, Baginska A, Brogan P, Papadopoulou C, Rezk T, Hawkins PN, Lachmann HJ (2020) British kindred with dominant FMF associated with high incidence of AA amyloidosis caused by novel MEFV variant, and a review of the literature. Rheumatology 59(3):554–558. https://​doi.​org/​10.​1093/​rheumatology/​kez334CrossRefPubMed
8.
Zurück zum Zitat Kasifoglu T, Bilge SY, Sari I, Solmaz D, Senel S, Emmungil H, Kilic L, Oner SY, Yildiz F, Yilmaz S, Bakirli DE, Tufan MA, Yilmaz S, Yazisiz V, Pehlivan Y, Bes C, Cetin GY, Erten S, Gonullu E, Temel T, Sahin F, Akar S, Aksu K, Kalyoncu U, Direskeneli H, Erken E, Kisacik B, Sayarlioglu M, Korkmaz C (2014) Amyloidosis and its related factors in Turkish patients with familial Mediterranean fever: a multicentre study. Rheumatology 53(4):741–745. https://doi.org/10.1093/rheumatology/ket400CrossRefPubMed Kasifoglu T, Bilge SY, Sari I, Solmaz D, Senel S, Emmungil H, Kilic L, Oner SY, Yildiz F, Yilmaz S, Bakirli DE, Tufan MA, Yilmaz S, Yazisiz V, Pehlivan Y, Bes C, Cetin GY, Erten S, Gonullu E, Temel T, Sahin F, Akar S, Aksu K, Kalyoncu U, Direskeneli H, Erken E, Kisacik B, Sayarlioglu M, Korkmaz C (2014) Amyloidosis and its related factors in Turkish patients with familial Mediterranean fever: a multicentre study. Rheumatology 53(4):741–745. https://​doi.​org/​10.​1093/​rheumatology/​ket400CrossRefPubMed
12.
Zurück zum Zitat Ben-Chetrit E, Levy M (1998) Familial Mediterranean fever. Lancet 351(9103):659–664CrossRef Ben-Chetrit E, Levy M (1998) Familial Mediterranean fever. Lancet 351(9103):659–664CrossRef
15.
Zurück zum Zitat Gangemi S, Manti S, Procopio V, Casciaro M, Di Salvo E, Cutrupi M, Ganci G, Salpietro C, Chimenz R, Cuppari C (2018) Lack of clear and univocal genotype-phenotype correlation in familial Mediterranean fever patients: a systematic review. Clin Genet 94(1):81–94. https://doi.org/10.1111/cge.13223CrossRefPubMed Gangemi S, Manti S, Procopio V, Casciaro M, Di Salvo E, Cutrupi M, Ganci G, Salpietro C, Chimenz R, Cuppari C (2018) Lack of clear and univocal genotype-phenotype correlation in familial Mediterranean fever patients: a systematic review. Clin Genet 94(1):81–94. https://​doi.​org/​10.​1111/​cge.​13223CrossRefPubMed
22.
Zurück zum Zitat Atoyan S, Hayrapetyan H, Yeghiazaryan A, Ben-Chetrit E, Sarkisian T (2020) Is the country of living important in the phenotypic expression of E148Q mutation? The Armenian experience. Clin Exp Rheumatol 127(5):124–125 Atoyan S, Hayrapetyan H, Yeghiazaryan A, Ben-Chetrit E, Sarkisian T (2020) Is the country of living important in the phenotypic expression of E148Q mutation? The Armenian experience. Clin Exp Rheumatol 127(5):124–125
25.
Zurück zum Zitat Van Gorp H, Huang L, Saavedra P, Vuylsteke M, Asaoka T, Prencipe G, Insalaco A, Ogunjimi B, Jeyaratnam J, Cataldo I, Jacques P, Vermaelen K, Dullaers M, Joos R, Sabato V, Stella A, Frenkel J, De Benedetti F, Dehoorne J, Haerynck F, Calamita G, Portincasa P, Lamkanfi M (2020) Blood-based test for diagnosis and functional subtyping of familial Mediterranean fever. Ann Rheum Dis. https://doi.org/10.1136/annrheumdis-2019-216701CrossRefPubMed Van Gorp H, Huang L, Saavedra P, Vuylsteke M, Asaoka T, Prencipe G, Insalaco A, Ogunjimi B, Jeyaratnam J, Cataldo I, Jacques P, Vermaelen K, Dullaers M, Joos R, Sabato V, Stella A, Frenkel J, De Benedetti F, Dehoorne J, Haerynck F, Calamita G, Portincasa P, Lamkanfi M (2020) Blood-based test for diagnosis and functional subtyping of familial Mediterranean fever. Ann Rheum Dis. https://​doi.​org/​10.​1136/​annrheumdis-2019-216701CrossRefPubMed
26.
Zurück zum Zitat Magnotti F, Malsot T, Georgin-Lavialle S, Abbas F, Martin A, Belot A, Fauter M, Rabilloud M, Gerfaud-Valentin M, Seve P, Duquesne A, Hot A, Durupt S, Savey L, Giurgea I, Grateau G, Henry T, Jamilloux Y (2021) Fast diagnostic test for familial Mediterranean fever based on a kinase inhibitor. Ann Rheum Dis 80(1):128–132. https://doi.org/10.1136/annrheumdis-2020-218366CrossRefPubMed Magnotti F, Malsot T, Georgin-Lavialle S, Abbas F, Martin A, Belot A, Fauter M, Rabilloud M, Gerfaud-Valentin M, Seve P, Duquesne A, Hot A, Durupt S, Savey L, Giurgea I, Grateau G, Henry T, Jamilloux Y (2021) Fast diagnostic test for familial Mediterranean fever based on a kinase inhibitor. Ann Rheum Dis 80(1):128–132. https://​doi.​org/​10.​1136/​annrheumdis-2020-218366CrossRefPubMed
27.
Zurück zum Zitat Honda Y, Maeda Y, Izawa K, Shiba T, Tanaka T, Nakaseko H, Nishimura K, Mukoyama H, Isa-Nishitani M, Miyamoto T, Nihira H, Shibata H, Hiejima E, Ohara O, Takita J, Yasumi T, Nishikomori R (2021) Rapid flow cytometry-based assay for the functional classification of MEFV variants. J Clin Immunol 41(6):1187–1197. https://doi.org/10.1007/s10875-021-01021-7CrossRefPubMed Honda Y, Maeda Y, Izawa K, Shiba T, Tanaka T, Nakaseko H, Nishimura K, Mukoyama H, Isa-Nishitani M, Miyamoto T, Nihira H, Shibata H, Hiejima E, Ohara O, Takita J, Yasumi T, Nishikomori R (2021) Rapid flow cytometry-based assay for the functional classification of MEFV variants. J Clin Immunol 41(6):1187–1197. https://​doi.​org/​10.​1007/​s10875-021-01021-7CrossRefPubMed
28.
Zurück zum Zitat Cazeneuve C, Ajrapetyan H, Papin S, Roudot-Thoraval F, Genevieve D, Mndjoyan E, Papazian M, Sarkisian A, Babloyan A, Boissier B, Duquesnoy P, Kouyoumdjian JC, Girodon-Boulandet E, Grateau G, Sarkisian T, Amselem S (2000) Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever. Am J Hum Genet 67(5):1136–1143PubMedPubMedCentral Cazeneuve C, Ajrapetyan H, Papin S, Roudot-Thoraval F, Genevieve D, Mndjoyan E, Papazian M, Sarkisian A, Babloyan A, Boissier B, Duquesnoy P, Kouyoumdjian JC, Girodon-Boulandet E, Grateau G, Sarkisian T, Amselem S (2000) Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever. Am J Hum Genet 67(5):1136–1143PubMedPubMedCentral
29.
Zurück zum Zitat Atoyan S, Hayrapetyan H, Sarkisian T, Ben-Chetrit E (2016) MEFV and SAA1 genotype associations with clinical features of familial Mediterranean fever and amyloidosis in Armenia. Clin Exp Rheumatol 34(102):72–76PubMed Atoyan S, Hayrapetyan H, Sarkisian T, Ben-Chetrit E (2016) MEFV and SAA1 genotype associations with clinical features of familial Mediterranean fever and amyloidosis in Armenia. Clin Exp Rheumatol 34(102):72–76PubMed
37.
Zurück zum Zitat Deshayes S, Fellahi S, Bastard JP, Launay JM, Callebert J, Fraisse T, Buob D, Boffa JJ, Giurgea I, Dupont C, Jegou S, Straube M, Karras A, Aouba A, Grateau G, Sokol H, Georgin-Lavialle S (2019) Specific changes in faecal microbiota are associated with familial Mediterranean fever. Ann Rheum Dis 78(10):1398–1404. https://doi.org/10.1136/annrheumdis-2019-215258CrossRefPubMed Deshayes S, Fellahi S, Bastard JP, Launay JM, Callebert J, Fraisse T, Buob D, Boffa JJ, Giurgea I, Dupont C, Jegou S, Straube M, Karras A, Aouba A, Grateau G, Sokol H, Georgin-Lavialle S (2019) Specific changes in faecal microbiota are associated with familial Mediterranean fever. Ann Rheum Dis 78(10):1398–1404. https://​doi.​org/​10.​1136/​annrheumdis-2019-215258CrossRefPubMed
38.
Zurück zum Zitat Ozen S, Lutz H, Rivera V, Reiff A, Batu E, Anderson E, Garcia MS, Aldrovandi G, Akbaba T, Pazarbasi İ (2021) Paediatric rheumatology Microbiome is not linked to clinical disease severity of familial Mediterranean fever in an international cohort of children. Clin Exp Rheumatol 39(132):S102–S108CrossRef Ozen S, Lutz H, Rivera V, Reiff A, Batu E, Anderson E, Garcia MS, Aldrovandi G, Akbaba T, Pazarbasi İ (2021) Paediatric rheumatology Microbiome is not linked to clinical disease severity of familial Mediterranean fever in an international cohort of children. Clin Exp Rheumatol 39(132):S102–S108CrossRef
Metadaten
Titel
The unsolved mystery of MEFV variants variable expressivity in Familial Mediterranean Fever
verfasst von
Alessandro Stella
Piero Portincasa
Publikationsdatum
09.07.2022
Verlag
Springer International Publishing
Erschienen in
Internal and Emergency Medicine / Ausgabe 5/2022
Print ISSN: 1828-0447
Elektronische ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-022-03027-4

Weitere Artikel der Ausgabe 5/2022

Internal and Emergency Medicine 5/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.